Poster Abstract Session:
253. Vaccines for Herpes Zoster Virus
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID


Presentations:
Impact of the Vaccination Strategy on Varicella Burden Disease in Argentina
Silvina Neyro, MD; Carolina Rancaño, MD; Maria Iglesias, MD; Nathalia Katz, MD; María Del Valle Juarez, MD; Marina Pasinovich, MD; Martin Saralegui, BEd; Cristián Biscayart, MD
Posters
  • Varicela IDWeek 2018...pdf (622.5 kB)
  • Impact of Varicella Vaccination in the United States (US): a Dynamic Model-Based Analysis
    Lara Wolfson, PhD; Jeffrey Kyle, MS; Barbara Kuter, PhD, MPH; Myron Levin, MD, FIDSA; Vincent Daniels, PhD
    Real-world Effectiveness of the Live Zoster Vaccine in Preventing Herpes Zoster: A Systematic Review
    Patricia Saddier, MD, PhD; Morgan A. Marks, PhD; Shawna Calhoun, MPH; Kelly Johnson, PhD, MPH; Yola Moride, PhD, FISPE
    Impact of sex and race/ethnicity on the effectiveness of live zoster vaccine
    Morgan A. Marks, PhD; Joan Bartlett, MPH, MPP; Bruce Fireman, MA; John Hansen, MPH; Ned Lewis, MPH; Laurie Aukes, RN; Patricia Saddier, MD, PhD; Nicola P. Klein, MD, PhD
    Impact of a Recombinant Zoster Vaccine on Quality of Life: Data from a Randomized, Placebo-Controlled, Phase 3 Trial in Adult Hematopoietic Stem Cell Transplant Recipients
    Desmond Curran, PhD; Achilles Anagnostopoulos, MD; Ibrahim Barista, MD; Adriana Bastidas, PhD; Pranatharthi Chandrasekar, MD; Michael Dickinson, MBBS FRACP FRCPA DMED SCI; Inmaculada Heras, PhD; Mohamed El Idrissi, MSc; Sean Matthews, MSc; Samuel Milliken, MBBS FRACP FRCPA; Jorge Monserrat Coll, MD; Maria Belen Navarro Matilla, MA, MBBS; Lidia Oostvogels, MD; Dimas Quiel, MD; Scott Rowley, MD; Waleed Sabry, MD MSc Doctorate in Hematology; Dominik Selleslag, MD; Jeff Szer, MB BS FRACP; Koen Theunissen, MD; Zeynep Arzu Yegin, Assoc. Prof.; Su-Peng Yeh, MD; Jo-Anne Young, MD; Francesco Zaja, MD; Beata Piatkowska-Jakubas On Behalf Of The Zoe-Hsct Study Group, MD PhD Assoc Prof
    Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine in Immunosuppressed Adults Post Renal Transplant: a Phase III Randomized Clinical Trial
    Peter Vink, MD; Josep Maria Ramon Torrell, PhD, MD; Ana I. Sanchez-Fructuoso, PhD; Sung-Joo Kim, MD, PhD; Sang Il Kim, MD; Jeffrey Zaltzman, MD, FRCP (C); Fernanda Ortiz, MD, PhD; Josep Maria Campistol Plana, MD; Ana Maria Fernandez Rodriguez, MD, PhD; Henar Rebollo Rodrigo, MD, PhD; Magda Campins Marti, MD, PhD; Rafael Perez, MD; Francisco Manuel González-Roncero, MD; Deepali Kumar, MD Msc; Yang-Jen Chiang, MD; Karen Doucette, MD, MSc, FRCPC; Lissa Pipeleers, MD; Maria Luisa Agüera Morales, MD; Maria Luisa Rodriguez Ferrero, MD; Antonio Secchi, MD; Shelly A McNeil, MD, FIDSA; Laura Campora, MD; Emmanuel Di Paolo, MSc; Mohamed El Idrissi, MSc; Marta López-Fauqued, PhD; Bruno Salaun, PhD; Thomas Heineman, MD, PhD; Lidia Oostvogels, MD, On Behalf Of The Zoe-50/70 Study Group

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.